+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Tetanus Toxoid Vaccine Market 2024-2028

  • PDF Icon

    Report

  • 131 Pages
  • August 2024
  • Region: Global
  • TechNavio
  • ID: 5596141
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The tetanus toxoid vaccine market is forecasted to grow by USD 1.24 billion during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the tetanus toxoid vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by licensing agreements, rising cases of tetanus, diphtheria, and pertussis, and increasing government initiatives regarding vaccination and immunization.

The tetanus toxoid vaccine market is segmented as below:

By Age Group

  • Neonatals
  • Adults

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the new product launches as one of the prime reasons driving the tetanus toxoid vaccine market growth during the next few years. Also, increasing number of immunization campaigns and increasing clinical trials will lead to sizable demand in the market.

The report on the tetanus toxoid vaccine market covers the following areas:

  • Tetanus toxoid vaccine market sizing
  • Tetanus toxoid vaccine market forecast
  • Tetanus toxoid vaccine market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading tetanus toxoid vaccine market vendors that include Actiza Pharmaceutical Pvt. Ltd., AJ Vaccines AS, Amson Vaccines and Pharma Pvt Ltd., Avalon Pharma Pvt. Ltd., Bharat Biotech Ltd., CSL Ltd., Dano Vaccines and Biologicals Pvt. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Grifols SA, Incepta Vaccine Ltd., Meiji Holdings Co. Ltd., Merck and Co. Inc., Microgen, Panacea Biotec Ltd., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., and Zoetis Inc. Also, the tetanus toxoid vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Age Group
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Tetanus Toxoid Vaccine Market 2018 - 2022
Historic Market Size - Data Table on Global Tetanus Toxoid Vaccine Market 2018 - 2022 ($ million)
4.2 Age Group segment analysis 2018 - 2022
Historic Market Size - Age Group Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Age Group
6.1 Market segments
Chart on Age Group - Market share 2023-2028 (%)
Data Table on Age Group - Market share 2023-2028 (%)
6.2 Comparison by Age Group
Chart on Comparison by Age Group
Data Table on Comparison by Age Group
6.3 Neonatals - Market size and forecast 2023-2028
Chart on Neonatals - Market size and forecast 2023-2028 ($ million)
Data Table on Neonatals - Market size and forecast 2023-2028 ($ million)
Chart on Neonatals - Year-over-year growth 2023-2028 (%)
Data Table on Neonatals - Year-over-year growth 2023-2028 (%)
6.4 Adults - Market size and forecast 2023-2028
Chart on Adults - Market size and forecast 2023-2028 ($ million)
Data Table on Adults - Market size and forecast 2023-2028 ($ million)
Chart on Adults - Year-over-year growth 2023-2028 (%)
Data Table on Adults - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Age Group
Market opportunity by Age Group ($ million)
Data Table on Market opportunity by Age Group ($ million)
7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.10 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
8.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Avalon Pharma Pvt. Ltd.
Avalon Pharma Pvt. Ltd. - Overview
Avalon Pharma Pvt. Ltd. - Product/Service
Avalon Pharma Pvt. Ltd. - Key offerings
11.4 Bharat Biotech Ltd.
Bharat Biotech Ltd. - Overview
Bharat Biotech Ltd. - Product/Service
Bharat Biotech Ltd. - Key offerings
11.5 Emergent BioSolutions Inc.
Emergent BioSolutions Inc. - Overview
Emergent BioSolutions Inc. - Product/Service
Emergent BioSolutions Inc. - Key offerings
11.6 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
11.7 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
11.8 Panacea Biotec Ltd.
Panacea Biotec Ltd. - Overview
Panacea Biotec Ltd. - Product/Service
Panacea Biotec Ltd. - Key news
Panacea Biotec Ltd. - Key offerings
11.9 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product/Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
11.10 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
11.11 Serum Institute of India Pvt. Ltd.
Serum Institute of India Pvt. Ltd. - Overview
Serum Institute of India Pvt. Ltd. - Product/Service
Serum Institute of India Pvt. Ltd. - Key offerings
11.12 Shenzhen Kangtai Biological Products Co. Ltd.
Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Shenzhen Kangtai Biological Products Co. Ltd. - Product/Service
Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Age Group
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Tetanus Toxoid Vaccine Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Age Group Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Age Group - Market share 2023-2028 (%)
Exhibits 31: Data Table on Age Group - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Age Group
Exhibits 33: Data Table on Comparison by Age Group
Exhibits 34: Chart on Neonatals - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Neonatals - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Neonatals - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Neonatals - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Adults - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Adults - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Adults - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Adults - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Age Group ($ million)
Exhibits 43: Data Table on Market opportunity by Age Group ($ million)
Exhibits 44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 47: Chart on Geographic comparison
Exhibits 48: Data Table on Geographic comparison
Exhibits 49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 85: Market opportunity By Geographical Landscape ($ million)
Exhibits 86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 87: Impact of drivers and challenges in 2023 and 2028
Exhibits 88: Overview on criticality of inputs and factors of differentiation
Exhibits 89: Overview on factors of disruption
Exhibits 90: Impact of key risks on business
Exhibits 91: Companies covered
Exhibits 92: Matrix on companies position and classification
Exhibits 93: Avalon Pharma Pvt. Ltd. - Overview
Exhibits 94: Avalon Pharma Pvt. Ltd. - Product/Service
Exhibits 95: Avalon Pharma Pvt. Ltd. - Key offerings
Exhibits 96: Bharat Biotech Ltd. - Overview
Exhibits 97: Bharat Biotech Ltd. - Product/Service
Exhibits 98: Bharat Biotech Ltd. - Key offerings
Exhibits 99: Emergent BioSolutions Inc. - Overview
Exhibits 100: Emergent BioSolutions Inc. - Product/Service
Exhibits 101: Emergent BioSolutions Inc. - Key offerings
Exhibits 102: GlaxoSmithKline Plc - Overview
Exhibits 103: GlaxoSmithKline Plc - Business segments
Exhibits 104: GlaxoSmithKline Plc - Key news
Exhibits 105: GlaxoSmithKline Plc - Key offerings
Exhibits 106: GlaxoSmithKline Plc - Segment focus
Exhibits 107: Merck and Co. Inc. - Overview
Exhibits 108: Merck and Co. Inc. - Business segments
Exhibits 109: Merck and Co. Inc. - Key news
Exhibits 110: Merck and Co. Inc. - Key offerings
Exhibits 111: Merck and Co. Inc. - Segment focus
Exhibits 112: Panacea Biotec Ltd. - Overview
Exhibits 113: Panacea Biotec Ltd. - Product/Service
Exhibits 114: Panacea Biotec Ltd. - Key news
Exhibits 115: Panacea Biotec Ltd. - Key offerings
Exhibits 116: Pfizer Inc. - Overview
Exhibits 117: Pfizer Inc. - Product/Service
Exhibits 118: Pfizer Inc. - Key news
Exhibits 119: Pfizer Inc. - Key offerings
Exhibits 120: Sanofi SA - Overview
Exhibits 121: Sanofi SA - Business segments
Exhibits 122: Sanofi SA - Key news
Exhibits 123: Sanofi SA - Key offerings
Exhibits 124: Sanofi SA - Segment focus
Exhibits 125: Serum Institute of India Pvt. Ltd. - Overview
Exhibits 126: Serum Institute of India Pvt. Ltd. - Product/Service
Exhibits 127: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits 128: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Exhibits 129: Shenzhen Kangtai Biological Products Co. Ltd. - Product/Service
Exhibits 130: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
Exhibits 131: Inclusions checklist
Exhibits 132: Exclusions checklist
Exhibits 133: Currency conversion rates for US$
Exhibits 134: Research methodology
Exhibits 135: Information sources
Exhibits 136: Data validation
Exhibits 137: Validation techniques employed for market sizing
Exhibits 138: Data synthesis
Exhibits 139: 360 degree market analysis
Exhibits 140: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global tetanus toxoid vaccine market: Actiza Pharmaceutical Pvt. Ltd., AJ Vaccines AS, Amson Vaccines and Pharma Pvt Ltd., Avalon Pharma Pvt. Ltd., Bharat Biotech Ltd., CSL Ltd., Dano Vaccines and Biologicals Pvt. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Grifols SA, Incepta Vaccine Ltd., Meiji Holdings Co. Ltd., Merck and Co. Inc., Microgen, Panacea Biotec Ltd., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., and Zoetis Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is new product launches."

According to the report, one of the major drivers for this market is the licensing agreements.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Actiza Pharmaceutical Pvt. Ltd.
  • AJ Vaccines AS
  • Amson Vaccines and Pharma Pvt Ltd.
  • Avalon Pharma Pvt. Ltd.
  • Bharat Biotech Ltd.
  • CSL Ltd.
  • Dano Vaccines and Biologicals Pvt. Ltd.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Grifols SA
  • Incepta Vaccine Ltd.
  • Meiji Holdings Co. Ltd.
  • Merck and Co. Inc.
  • Microgen
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.
  • Zoetis Inc.